? BIOMEDICAL RESEARCH SUPPORT SHARED RESOURCE New Cancer Center Support Grant Shared Resource The Biomedical Research Support Shared Resource (BRSSR) enables Cancer Center members to perform human subject research in the context of partnerships between Wistar investigators and clinical care providers. Introduced as a developmental core at the 2013 Cancer Center Support Grant (CCSG) renewal, the BRSSR has been launched as a full-service Cancer Center Shared Resource during the last CCSG budget cycle. By providing a centralized resource for human subject-based research at Wistar, the BRSSR makes available to Cancer Center investigators a comprehensive menu of services to (i) coordinate the procurement of human subject-derived biospecimens from clinical partners, volunteers (phlebotomy service) or commercial partners; (ii) provide expertise in fulfilling research compliance with ethical and regulatory mandates; (iii) assist investigators to ensure that biospecimen and data collection is conducted in compliance with Good Clinical Practice (GCP), regulatory mandates (e.g. 21 CFR Part 11, HIPAA etc.) and contractual obligations; (iv) provide access to tissue processing and advanced histotechnology techniques for specimens analysis; and (v) provide low-cost, customized solutions for centralized data storage and management that ensure the consistency, completeness and quality of the data received from clinical providers. Our collaborative partnership with the Helen F. Graham Cancer Center (HFGCC) at Christiana Care Health System (CCHS), a member Institution of the National Community Cancer Center Program (NCCCP), provides Wistar Cancer Center members with access to fresh biospecimens, including fine-needle aspirate, biopsies, surgical resections, and biological fluids from cancer patients, instrumental to fulfill the mission of the Cancer Center in translational and patient-focused cancer research. Substantial institutional investments have been made to develop and validate an electronic data management platform, CDETweb Toolbox, to manage human subject data in the BRSSR. As fully deployed, the CDETweb platform is customizable to meet specific data collection and sample tracking needs, supporting multiple data entry modes (e.g. keying and direct uploads), randomization, asymmetrical visit schedules, screening and entry criteria gatekeeping, and other custom-defined requirements. BRSSR services also support a phlebotomy service (protocol management, donor management, testing, etc.) and access to tissue microarray services (array design and customization, ordering and tracking). As a result, the BRSSR provides a robust infrastructure to support mechanistic, patient-oriented research by managing all aspects of procurement of human subject-derived biospecimens.
| Schug, Zachary T (2018) Formaldehyde Detoxification Creates a New Wheel for the Folate-Driven One-Carbon ""Bi""-cycle. Biochemistry 57:889-890 |
| Karakashev, Sergey; Zhu, Hengrui; Wu, Shuai et al. (2018) CARM1-expressing ovarian cancer depends on the histone methyltransferase EZH2 activity. Nat Commun 9:631 |
| Jenkins, Russell W; Aref, Amir R; Lizotte, Patrick H et al. (2018) Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids. Cancer Discov 8:196-215 |
| Barnoud, Thibaut; Budina-Kolomets, Anna; Basu, Subhasree et al. (2018) Tailoring Chemotherapy for the African-Centric S47 Variant of TP53. Cancer Res 78:5694-5705 |
| Barbieri, Elisa; Trizzino, Marco; Welsh, Sarah Ann et al. (2018) Targeted Enhancer Activation by a Subunit of the Integrator Complex. Mol Cell 71:103-116.e7 |
| Seo, Jae Ho; Agarwal, Ekta; Bryant, Kelly G et al. (2018) Syntaphilin Ubiquitination Regulates Mitochondrial Dynamics and Tumor Cell Movements. Cancer Res 78:4215-4228 |
| Lu, Huimin; Bowler, Nicholas; Harshyne, Larry A et al. (2018) Exosomal ?v?6 integrin is required for monocyte M2 polarization in prostate cancer. Matrix Biol 70:20-35 |
| Stout, Matthew C; Narayan, Shilpa; Pillet, Emily S et al. (2018) Inhibition of CX3CR1 reduces cell motility and viability in pancreatic adenocarcinoma epithelial cells. Biochem Biophys Res Commun 495:2264-2269 |
| Hu, Xiaowen; Sood, Anil K; Dang, Chi V et al. (2018) The role of long noncoding RNAs in cancer: the dark matter matters. Curr Opin Genet Dev 48:8-15 |
| Saglam, Ozlen; Conejo-Garcia, Jose (2018) PD-1/PD-L1 immune checkpoint inhibitors in advanced cervical cancer. Integr Cancer Sci Ther 5: |
Showing the most recent 10 out of 741 publications
